HMMR and prostate carcinoma: RHAMM, expressed in activated T cells, is an immunogenic antigen associated with inflammation, fibrosis, acute and chronic leukaemia, breast cancer, and prostate cancer, and plays an important role in the immune system by regulating immune cell movement [133,253].